124 related articles for article (PubMed ID: 8220147)
1. Therapy-related acute myelogenous leukemia associated with 11q23 chromosomal abnormalities and topoisomerase II inhibitors: report of four additional cases and brief commentary.
Bredeson CN; Barnett MJ; Horsman DE; Dalal BI; Ragaz J; Phillips GL
Leuk Lymphoma; 1993 Sep; 11(1-2):141-5. PubMed ID: 8220147
[TBL] [Abstract][Full Text] [Related]
2. Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risks.
Smith MA; Rubinstein L; Ungerleider RS
Med Pediatr Oncol; 1994; 23(2):86-98. PubMed ID: 8202047
[TBL] [Abstract][Full Text] [Related]
3. Therapy-related acute leukemia associated with t(11q23) after primary acute myeloid leukemia with t(8;21): a report of two cases.
Roulston D; Anastasi J; Rudinsky R; Nucifora G; Zeleznik-Le N; Rowley JD; McGavran L; Tsuchida M; Hayashi Y
Blood; 1995 Nov; 86(9):3613-4. PubMed ID: 7579475
[No Abstract] [Full Text] [Related]
4. Secondary acute myelogenous leukemia and myelodysplasia without abnormalities of chromosome 11q23 following treatment of acute leukemia with topoisomerase II-based chemotherapy.
Seiter K; Feldman EJ; Sreekantaiah C; Pozzuoli M; Weisberger J; Liu D; Papageorgio C; Weiss M; Kancherla R; Ahmed T
Leukemia; 2001 Jun; 15(6):963-70. PubMed ID: 11417484
[TBL] [Abstract][Full Text] [Related]
5. Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series.
Pedersen-Bjergaard J; Philip P; Larsen SO; Andersson M; Daugaard G; Ersbøll J; Hansen SW; Hou-Jensen K; Nielsen D; Sigsgaard TC
Leukemia; 1993 Dec; 7(12):1975-86. PubMed ID: 8255096
[TBL] [Abstract][Full Text] [Related]
6. A case of treatment-related myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemotherapy with autologous stem cell transplantation for non-Hodgkin's lymphoma.
Jang GD; Kim SW; Suh CW; Kim EK; Bahng HS; Jeong YH; Park IG; Kim WK; Kim SH; Suh EJ; Park CJ; Ji HS; Lee JS
J Korean Med Sci; 2002 Aug; 17(4):555-9. PubMed ID: 12172056
[TBL] [Abstract][Full Text] [Related]
7. Early secondary acute myelogenous leukemia in breast cancer patients after treatment with mitoxantrone, cyclophosphamide, fluorouracil and radiation therapy.
Linassier C; Barin C; Calais G; Letortorec S; Brémond JL; Delain M; Petit A; Georget MT; Cartron G; Raban N; Benboubker L; Leloup R; Binet C; Lamagnère JP; Colombat P
Ann Oncol; 2000 Oct; 11(10):1289-94. PubMed ID: 11106118
[TBL] [Abstract][Full Text] [Related]
8. MLL gene rearrangement in acute myelogenous leukemia after exposure to tegafur/uracil.
Fukushima T; Yoshio N; Noto Y; Kida H
Int J Hematol; 2002 Feb; 75(2):178-81. PubMed ID: 11939265
[TBL] [Abstract][Full Text] [Related]
9. [Therapy-related AML(M2) with t(8;21) that developed three years after chemotherapy for hepatocellular carcinoma].
Miyata A; Deguchi S; Fujita M; Kikuchi T; Honda K
Rinsho Ketsueki; 1996 May; 37(5):448-51. PubMed ID: 8691593
[TBL] [Abstract][Full Text] [Related]
10. Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors, and irradiation.
Sandoval C; Pui CH; Bowman LC; Heaton D; Hurwitz CA; Raimondi SC; Behm FG; Head DR
J Clin Oncol; 1993 Jun; 11(6):1039-45. PubMed ID: 8388919
[TBL] [Abstract][Full Text] [Related]
11. Acute myeloid leukaemia with t(9;11)(p22;q23) in a patient treated for adult T cell leukaemia.
Nakamura H; Ishizaki T; Itoyama T; Soda H; Yoshida Y; Yamada Y; Kuriyama K; Sadamori N; Tomonaga M
Br J Haematol; 1994 Jan; 86(1):222-4. PubMed ID: 8011538
[TBL] [Abstract][Full Text] [Related]
12. Therapy-related acute myelomonocytic leukemia following successful treatment for acute promyelocytic leukemia.
Todisco E; Testi AM; Avvisati G; Moleti ML; Cedrone M; Cimino G; Mancini F; Amadori S; Mandelli F
Leukemia; 1995 Sep; 9(9):1583-5. PubMed ID: 7658728
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy-related - late occurring - Philadelphia chromosome in AML, ALL and CML. Similar events related to treatment with DNA topoisomerase II inhibitors?
Pedersen-Bjergaard J; Brøndum-Nielsen K; Karle H; Johansson B
Leukemia; 1997 Sep; 11(9):1571-4. PubMed ID: 9305614
[TBL] [Abstract][Full Text] [Related]
14. A case of therapy-related acute myeloblastic leukemia with t(16;21)(q24;q22) after chemotherapy with DNA-topoisomerase II inhibitors, etoposide and mitoxantrone, and the alkylating agent, cyclophosphamide.
Takeda K; Shinohara K; Kameda N; Ariyoshi K
Int J Hematol; 1998 Feb; 67(2):179-86. PubMed ID: 9631585
[TBL] [Abstract][Full Text] [Related]
15. Implication of prior treatment with drug combinations including inhibitors of topoisomerase II in therapy-related monocytic leukemia with a 9;11 translocation.
Albain KS; Le Beau MM; Ullirsch R; Schumacher H
Genes Chromosomes Cancer; 1990 May; 2(1):53-8. PubMed ID: 2177642
[TBL] [Abstract][Full Text] [Related]
16. Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors?
Dissing M; Le Beau MM; Pedersen-Bjergaard J
J Clin Oncol; 1998 May; 16(5):1890-6. PubMed ID: 9586906
[TBL] [Abstract][Full Text] [Related]
17. High frequency of pro-B acute lymphoblastic leukemia in adults with secondary leukemia with 11q23 abnormalities.
Ishizawa S; Slovak ML; Popplewell L; Bedell V; Wrede JE; Carter NH; Snyder DS; Arber DA
Leukemia; 2003 Jun; 17(6):1091-5. PubMed ID: 12764373
[TBL] [Abstract][Full Text] [Related]
18. [Chromosome translocations and leukemias induced by inhibitors of topoisomerase II anticarcinogenic drugs].
Dassonneville L; Bailly C
Bull Cancer; 1998 Mar; 85(3):254-61. PubMed ID: 9752316
[TBL] [Abstract][Full Text] [Related]
19. [Secondary leukemia after etoposide treatment involved MLL gene rearrangement].
Iida H; Taji H; Iida M; Suzuki R; Sugihara T; Minami S; Kodera Y; Yamamoto K; Seto M; Ueda R
Rinsho Ketsueki; 1994 Jun; 35(6):569-75. PubMed ID: 8078192
[TBL] [Abstract][Full Text] [Related]
20. Acute myelogenous leukemia after treatment for malignant germ cell tumors in children.
Schneider DT; Hilgenfeld E; Schwabe D; Behnisch W; Zoubek A; Wessalowski R; Göbel U
J Clin Oncol; 1999 Oct; 17(10):3226-33. PubMed ID: 10506623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
